| Company Name: |
OPULENT PHARMA
|
| Tel: |
+91-9106692785 +91-9106692785 |
| Email: |
info@opulentpharma.com |
| Products Intro: |
Product Name:Bortezomib Impurity H
CAS:1446194-56-4
Purity:98% Package:1 kg,5 kg, 10 kg,25kg and 1 MT
|
|
| | bortezoMib iMpurity H Basic information |
| Product Name: | bortezoMib iMpurity H | | Synonyms: | (S)-N-(1-(isopentylaMino)-1-oxo-3-phenylpropan-2-yl)pyrazine-2-carboxaMide;Bortezomib Imp.H;Bortezomib Impurity S;Bortezomib impurity 11/(S)-N-(1-(Isopentylamino)-1-oxo-3-phenylpropan-2-yl)pyrazine-2-carboxamide;2-Pyrazinecarboxamide, N-[(1S)-2-[(3-methylbutyl)amino]-2-oxo-1-(phenylmethyl)ethyl]-;Bortezomib impurity H | | CAS: | 1446194-56-4 | | MF: | C19H24N4O2 | | MW: | 340.42 | | EINECS: | | | Product Categories: | | | Mol File: | 1446194-56-4.mol |  |
| | bortezoMib iMpurity H Chemical Properties |
| solubility | Chloroform (Slightly), Dichloromethane (Slightly) | | form | Solid | | color | White to Off-White |
| | bortezoMib iMpurity H Usage And Synthesis |
| Uses | N-[(1S)-2-[(3-Methylbutyl)amino]-2-oxo-1-(phenylmethyl)ethyl]-2-pyrazinecarboxamide is an impurity of Bortezomib (B675700) which is the first proteasome inhibitor to be approved by the US FDA for multiple myeloma, a blood cancer. A reversible inhibitor of the 26S proteasome-a barrel-shaped multiprotein particle found in the nucleus and cytosol of all eukaryotic cells. Targets the ubiquitin-proteasome pathway. |
| | bortezoMib iMpurity H Preparation Products And Raw materials |
|